639 related articles for article (PubMed ID: 22859216)
21. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.
Schneider C; Teufel A; Yevsa T; Staib F; Hohmeyer A; Walenda G; Zimmermann HW; Vucur M; Huss S; Gassler N; Wasmuth HE; Lira SA; Zender L; Luedde T; Trautwein C; Tacke F
Gut; 2012 Dec; 61(12):1733-43. PubMed ID: 22267597
[TBL] [Abstract][Full Text] [Related]
22. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity.
Matsuzawa A; Saegusa K; Noguchi T; Sadamitsu C; Nishitoh H; Nagai S; Koyasu S; Matsumoto K; Takeda K; Ichijo H
Nat Immunol; 2005 Jun; 6(6):587-92. PubMed ID: 15864310
[TBL] [Abstract][Full Text] [Related]
23. Chronic inflammatory IFN-γ signaling suppresses hepatocarcinogenesis in mice by sensitizing hepatocytes for apoptosis.
Lüth S; Schrader J; Zander S; Carambia A; Buchkremer J; Huber S; Reifenberg K; Yamamura K; Schirmacher P; Lohse AW; Herkel J
Cancer Res; 2011 Jun; 71(11):3763-71. PubMed ID: 21512142
[TBL] [Abstract][Full Text] [Related]
24. PKR regulates TLR2/TLR4-dependent signaling in murine alveolar macrophages.
Cabanski M; Steinmüller M; Marsh LM; Surdziel E; Seeger W; Lohmeyer J
Am J Respir Cell Mol Biol; 2008 Jan; 38(1):26-31. PubMed ID: 17690330
[TBL] [Abstract][Full Text] [Related]
25. Leptospiral membrane proteins stimulate pro-inflammatory chemokines secretion by renal tubule epithelial cells through toll-like receptor 2 and p38 mitogen activated protein kinase.
Hung CC; Chang CT; Tian YC; Wu MS; Yu CC; Pan MJ; Vandewalle A; Yang CW
Nephrol Dial Transplant; 2006 Apr; 21(4):898-910. PubMed ID: 16339163
[TBL] [Abstract][Full Text] [Related]
26. SJSZ glycoprotein (38kDa) prevents thymus atrophy and enhances expression of IL-2 and IL-12 in diethylnitrosamine-induced hepatocarcinogenesis.
Lee J; Lim KT
Int Immunopharmacol; 2012 Jul; 13(3):362-9. PubMed ID: 22569343
[TBL] [Abstract][Full Text] [Related]
27. ASK1-p38 MAPK-p47phox activation is essential for inflammatory responses during tuberculosis via TLR2-ROS signalling.
Yang CS; Shin DM; Lee HM; Son JW; Lee SJ; Akira S; Gougerot-Pocidalo MA; El-Benna J; Ichijo H; Jo EK
Cell Microbiol; 2008 Mar; 10(3):741-54. PubMed ID: 18028450
[TBL] [Abstract][Full Text] [Related]
28. Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents.
Yu LX; Yan HX; Liu Q; Yang W; Wu HP; Dong W; Tang L; Lin Y; He YQ; Zou SS; Wang C; Zhang HL; Cao GW; Wu MC; Wang HY
Hepatology; 2010 Oct; 52(4):1322-33. PubMed ID: 20803560
[TBL] [Abstract][Full Text] [Related]
29. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
[TBL] [Abstract][Full Text] [Related]
30. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages.
Toshchakov V; Jones BW; Perera PY; Thomas K; Cody MJ; Zhang S; Williams BR; Major J; Hamilton TA; Fenton MJ; Vogel SN
Nat Immunol; 2002 Apr; 3(4):392-8. PubMed ID: 11896392
[TBL] [Abstract][Full Text] [Related]
31. TLR 2 induces vascular smooth muscle cell migration through cAMP response element-binding protein-mediated interleukin-6 production.
Lee GL; Chang YW; Wu JY; Wu ML; Wu KK; Yet SF; Kuo CC
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2751-60. PubMed ID: 22995520
[TBL] [Abstract][Full Text] [Related]
32. TLR-mediated distinct IFN-γ/IL-10 pattern induces protective immunity against murine visceral leishmaniasis.
Paul J; Karmakar S; De T
Eur J Immunol; 2012 Aug; 42(8):2087-99. PubMed ID: 22622993
[TBL] [Abstract][Full Text] [Related]
33. Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function.
Hu CE; Gan J; Zhang RD; Cheng YR; Huang GJ
Scand J Gastroenterol; 2011 Feb; 46(2):156-64. PubMed ID: 20822377
[TBL] [Abstract][Full Text] [Related]
34. Hepatocellular carcinoma-derived high mobility group box 1 triggers M2 macrophage polarization via a TLR2/NOX2/autophagy axis.
Shiau DJ; Kuo WT; Davuluri GVN; Shieh CC; Tsai PJ; Chen CC; Lin YS; Wu YZ; Hsiao YP; Chang CP
Sci Rep; 2020 Aug; 10(1):13582. PubMed ID: 32788720
[TBL] [Abstract][Full Text] [Related]
35. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
36. Serine 727 phosphorylation of STAT3: an early change in mouse hepatocarcinogenesis induced by neonatal treatment with diethylnitrosamine.
Miyakoshi M; Yamamoto M; Tanaka H; Ogawa K
Mol Carcinog; 2014 Jan; 53(1):67-76. PubMed ID: 22911886
[TBL] [Abstract][Full Text] [Related]
37. Selective synergy in anti-inflammatory cytokine production upon cooperated signaling via TLR4 and TLR2 in murine conventional dendritic cells.
Hirata N; Yanagawa Y; Ebihara T; Seya T; Uematsu S; Akira S; Hayashi F; Iwabuchi K; Onoé K
Mol Immunol; 2008 May; 45(10):2734-42. PubMed ID: 18372043
[TBL] [Abstract][Full Text] [Related]
38. Type I, but not type II, interferon is critical in liver injury induced after ischemia and reperfusion.
Zhai Y; Qiao B; Gao F; Shen X; Vardanian A; Busuttil RW; Kupiec-Weglinski JW
Hepatology; 2008 Jan; 47(1):199-206. PubMed ID: 17935177
[TBL] [Abstract][Full Text] [Related]
39. Growth arrest and DNA damage 45G down-regulation contributes to Janus kinase/signal transducer and activator of transcription 3 activation and cellular senescence evasion in hepatocellular carcinoma.
Zhang L; Yang Z; Ma A; Qu Y; Xia S; Xu D; Ge C; Qiu B; Xia Q; Li J; Liu Y
Hepatology; 2014 Jan; 59(1):178-89. PubMed ID: 23897841
[TBL] [Abstract][Full Text] [Related]
40. Role of insulin receptor substrates in the progression of hepatocellular carcinoma.
Sakurai Y; Kubota N; Takamoto I; Obata A; Iwamoto M; Hayashi T; Aihara M; Kubota T; Nishihara H; Kadowaki T
Sci Rep; 2017 Jul; 7(1):5387. PubMed ID: 28710407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
